Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Eplerenone effectively treats hypertension and aldosterone-induced damage in CV organs

Nov. 9, 1998

Novel 5-HT1B receptor antagonist presented this week by Astra Arcus

Nov. 9, 1998

Avasimibe a protagonist at the AHA's 71st scientific sessions

Nov. 9, 1998

Further evidence of the potential utility of BO-653 in restenosis

Nov. 9, 1998

GABA-B antagonist from Novartis with potential in epilepsy-associated memory disturbances

Nov. 6, 1998

Selective agonist activity of Bayer's Bay-x-3702 at 5-HT1A receptors confirmed in vivo

Nov. 6, 1998

Single- and multiple-dose safety, PK studies conducted with M-100907 in healthy volunteers

Nov. 6, 1998

Favorable efficacy, side effect profile seen with belaperidone in preclinical and clinical studies

Nov. 6, 1998

Phase II trial supports efficacy of pentapeptide antidepressant

Nov. 6, 1998

Merck finally reveals chemical structure of lead COX-2 inhibitor

Nov. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...